1. Home
  2. SION vs FFWM Comparison

SION vs FFWM Comparison

Compare SION & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • FFWM
  • Stock Information
  • Founded
  • SION 2019
  • FFWM 1990
  • Country
  • SION United States
  • FFWM United States
  • Employees
  • SION N/A
  • FFWM N/A
  • Industry
  • SION
  • FFWM Major Banks
  • Sector
  • SION
  • FFWM Finance
  • Exchange
  • SION NYSE
  • FFWM Nasdaq
  • Market Cap
  • SION 338.0M
  • FFWM 378.0M
  • IPO Year
  • SION 2025
  • FFWM 2014
  • Fundamental
  • Price
  • SION $12.57
  • FFWM $5.21
  • Analyst Decision
  • SION Strong Buy
  • FFWM Buy
  • Analyst Count
  • SION 1
  • FFWM 4
  • Target Price
  • SION $32.00
  • FFWM $6.75
  • AVG Volume (30 Days)
  • SION 128.6K
  • FFWM 948.7K
  • Earning Date
  • SION 05-25-2025
  • FFWM 04-30-2025
  • Dividend Yield
  • SION N/A
  • FFWM N/A
  • EPS Growth
  • SION N/A
  • FFWM N/A
  • EPS
  • SION N/A
  • FFWM N/A
  • Revenue
  • SION N/A
  • FFWM $113,564,000.00
  • Revenue This Year
  • SION N/A
  • FFWM $195.68
  • Revenue Next Year
  • SION N/A
  • FFWM $11.62
  • P/E Ratio
  • SION N/A
  • FFWM N/A
  • Revenue Growth
  • SION N/A
  • FFWM N/A
  • 52 Week Low
  • SION $7.26
  • FFWM $4.42
  • 52 Week High
  • SION $25.19
  • FFWM $8.52
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • FFWM 56.49
  • Support Level
  • SION N/A
  • FFWM $5.13
  • Resistance Level
  • SION N/A
  • FFWM $5.44
  • Average True Range (ATR)
  • SION 0.00
  • FFWM 0.24
  • MACD
  • SION 0.00
  • FFWM 0.04
  • Stochastic Oscillator
  • SION 0.00
  • FFWM 67.57

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

Share on Social Networks: